Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.

Azoulay, D; Lemoine, A; Gries, J M; Adam, R; Dolizy, I; Fredj, G; Beaune, P; Bismuth, H

Azoulay, D; Lemoine, A; Gries, J M; Adam, R; Dolizy, I; Fredj, G; Beaune, P; Bismuth, H.

Affiliation

Azoulay D; Hepatobiliary Surgery and Liver Transplant Research Unit, Paul Brousse Hospital, Villejuif, France.

Transplant Proc ; 25(3): 2275-8, 1993 Jun.

Article in En | MEDLINE | ID: mdl-8516899

Subject(s)

Cyclosporine/therapeutic use; Lidocaine/analogs & derivatives; Liver Function Tests; Liver Transplantation/physiology; Liver/metabolism; Tissue Donors; Adolescent; Adult; Aged; Brain Death; Child; Cytochrome P-450 Enzyme System/analysis; Female; Humans; Isoenzymes/analysis; Lidocaine/blood; Liver Transplantation/immunology; Male; Middle Aged; Prognosis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Liver Transplantation / Cyclosporine / Lidocaine / Liver / Liver Function Tests Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 1993 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links